Clinical Trial Update: Intranasal Ketorolac Tromethamine (Sprix) for Acute Pain of Interstitial Cystitis Flare of Pain [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating intranasal ketorolac tromethamine (Sprix) for acute pain during flares of interstitial cystitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Cystitis

Drugs mentioned

• SPRIX (ketorolac tromethamine)

Snippet

Sponsor: Citrus Valley Medical Research, Inc. | Conditions: Interstitial Cystitis | Phase 4 | Status: COMPLETED